Case Study: FAPI PET/CT Identifies Hidden Contralateral DCIS and Supraclavicular Metastasis, Informing Neoadjuvant Treatment in Synchronous Bilateral Breast Cancer - Top-Institutions - MDSpire

Case Study: FAPI PET/CT Identifies Hidden Contralateral DCIS and Supraclavicular Metastasis, Informing Neoadjuvant Treatment in Synchronous Bilateral Breast Cancer

  • By

  • Lin Cong

  • Bin Ji

  • Yiqi Gu

  • Yilin Wu

  • Wan Wang

  • April 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Nuclear Medicine
    • Breast Oncology
    • Molecular Imaging

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Cancer Research
    • Nuclear Medicine
    • Oncology Imaging

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Oncology
    • Nuclear Medicine
    • Translational Imaging Research

  • #4

    University of Heidelberg, Department of Nuclear Medicine
    University of Heidelberg, Department of Nuclear Medicine

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Nuclear Medicine
    • Oncologic Imaging
    • Breast Cancer

  • #5

    National Cancer Center Hospital
    National Cancer Center Hospital

    Tokyo, Tokyo

    Key Differentiators

    • Breast Cancer Imaging
    • Nuclear Medicine
    • Oncology

Original Source(s)

Case Study: FAPI PET/CT Identifies Hidden Contralateral DCIS and Supraclavicular Metastasis, Informing Neoadjuvant Treatment in Synchronous Bilateral Breast Cancer

  • by Lin Cong, Bin Ji, Yiqi Gu, Yilin Wu, Wan Wang

  • April 24, 2026

Related Content

Vitamin D-related genetic variants as predictive biomarkers for breast cancer in Jordanian women

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer